Elderly mice suffering from age-related heart disease saw a significant improvement in cardiac function after being treated with the FDA-approved drug rapamycin for just three months.
The research, led by a team of scientists at the Buck Institute for Research on Aging, shows how rapamycin impacts mammalian tissues, providing functional insights and possible benefits for a drug that has been shown to extend the lifespan of mice as much as 14 percent. There are implications for human health in the research appearing online in Aging Cell: heart disease is the leading cause of death in the U.S., claiming nearly 600,000 lives per year.
Rapamycin is an immunosuppressant drug which can be used to help prevent organ rejection after transplantation. It is also included in treatment regimens for some cancers. In this study, rapamycin was added to the diets of mice that were 24 months old – the human equivalent of 70 to 75 years of age. Similar to humans, the aged mice exhibited enlarged hearts, a general thickening of the heart wall and a reduced efficiency in the hearts ability to pump blood.
The mice were examined with ultrasound echocardiography before and after the three-month treatment period – using metrics closely paralleling those used in humans. Buck Institute faculty Simon Melov, PhD, the senior author of the study, said age-related cardiac dysfunction was either slowed or reversed in the treated mice. “When we measured the efficiency of how the heart pumps blood, the treated mice showed a remarkable improvement from where they started. In contrast, the untreated mice saw a general decline in pumping efficiency at the end of the same three month period,” he said. “This study provides the first evidence that age-related heart dysfunction can be improved even in late life via appropriate drug treatment,” added Melov, who said the treated mice saw a reduction in heart size, reduced stress signaling in heart tissues and a reduction in inflammation.
Buck researchers, utilizing genome analysis tools, uncovered suites of related genes which rapamycin modulates in the heart. “Rapamycin affected the expression of genes involved in calcium regulation, mitochondrial metabolism, hypertrophy and inflammation,” said Melov. “We also carried out behavioral assessments which showed the treated mice spent more time on running wheels than the mice who aged without intervention.”
“Little has been known about the functional ramifications of rapamycin in mammalian tissues,” said Buck Institute President and CEO Brian Kennedy, PhD, a co-author of the paper. “These findings are significant because we have no interest in simply extending lifespan without an accompanying improvement in the health and quality of life.” He added, “It is particularly encouraging that, in this case, an already-approved drug that extends lifespan also improved function late in life.”
The Latest Bing News on:
Age-Related Heart Disease
- People with rare longevity mutations may also be protected against cardiovascular disease: Studyon April 27, 2024 at 3:05 am
(Shutterstock) GHRD, which is defined by the body's inability to use its growth hormone and leads to stunted development, has been linked in mice to a 40 per cent increase in longevity and decreased ...
- Heart Failure Mortality Higher Now Than in 1999on April 26, 2024 at 12:41 pm
There needs to be a “focus on prevention of diseases and a redesign of how we deliver care,” says Marat Fudim.
- Rare condition that stunts growth also reduces heart attack riskon April 26, 2024 at 9:43 am
People with an ultra-rare condition that stunts growth are less likely to suffer a heart attack or stroke, suggests new research. The few hundred patients worldwide with growth hormone receptor ...
- Irregular bone marrow cells may increase heart disease riskon April 26, 2024 at 4:00 am
Over time, bone marrow stem cells develop key genetic errors and pass them on to immune cells. This may increase the risk of developing heart disease.
- Air pollution and depression linked with heart disease deaths in middle-aged adultson April 26, 2024 at 1:40 am
A study in more than 3,000 US counties, with 315 million residents, has suggested that air pollution is linked with stress and depression, putting under-65-year-olds at increased risk of dying from ...
- Exact dementia superfoods to eat and at what age to also stop high blood pressure and heart problemson April 25, 2024 at 10:04 pm
Dr Federica Amati appeared on This Morning to discuss the 'superfoods' people should be eating in each decade of their lives to prevent serious health conditions such as dementia, heart problems and h ...
- Study: Women with heart disease prescribed cholesterol-lowering drugs less often than menon April 25, 2024 at 3:36 am
Women with heart disease may be prescribed cholesterol-reducing statins less frequently than men, contravening recommended treatment guidelines, according to new research released Thursday.
- Women’s Heart Disease Is Under-Diagnosed, But New Scoring System Could Help Solve This Problemon April 24, 2024 at 10:07 pm
The scoring system used to predict a person’s risk of cardiovascular disease needs to get an upgrade to ensure it accounts for risk factors specifically affecting women, according to a study published ...
- Why are younger adults developing this common heart condition?on April 24, 2024 at 9:09 am
New research suggests that A-fib may be more prevalent, and more dangerous, in people under 65 than previously thought.
- Decline in heart failure deaths has been undone, led by people under 45on April 24, 2024 at 9:04 am
In heart failure, "the paradox is that at a time that we're seeing these increases in mortality, we also have access to better medications,” Mount Sinai Morningside's chief of cardiology said.
The Latest Google Headlines on:
Age-Related Heart Disease
[google_news title=”” keyword=”Age-Related Heart Disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Rapamycin
- Why Is Biodexa (BDRX) Up 70% Today?on April 26, 2024 at 4:18 pm
Oncology specialist Biodexa inked a compelling licensing deal to treat a serious disease, and BDRX stock popped sharply higher.More From InvestorPlace The #1 AI Investment Might Be This Company You’ve ...
- Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)on April 26, 2024 at 7:30 am
Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP) Worldwide rights come with $17 million in non-dilutive grant funding ...
- Biodexa shares rally 126% on rapamycin licensing dealon April 26, 2024 at 6:56 am
Shares of Biodexa (NASDAQ:BDRX) soared 126% in early trading Friday after the company announced it had entered into an exclusive worldwide license to develop and commercialize eRapa, also known as ...
- Science is closing in on the frailties of old ageon April 26, 2024 at 6:00 am
Research is finding way to extend animal lifespans but regulators are still wary of treating ageing as a disease ...
- Top 6 Best Rapamycin Supplements in 2024on April 25, 2024 at 5:00 pm
Rapamycin, a natural compound, has shown anti-aging and health benefits in various researches. Consequently, the popularity and demand for rapamycin supplements have surged significantly in the ...
- Could delaying menopause boost women's health? 1 woman shares her storyon April 25, 2024 at 4:56 am
(Double-blind means no one knows who receives the treatment and who receives the placebo.) Subjects are randomized to receive either rapamycin or a placebo. For three months, participants take a pill, ...
- Experimental Ovarian Tissue Freezing Could Delay Menopause, but Experts Are Weighing the Riskson April 22, 2024 at 5:00 am
Extracting, freezing and retransplanting slices of hormone-producing ovarian tissue could postpone menopause, but some experts say it’s not effective enough—or necessary ...
- Rapamycin: The Drug with a Potential to Extend Life and Combat Age-Related Diseaseson April 18, 2024 at 12:07 pm
Rapamycin, a drug traditionally used to prevent organ transplant rejection, has garnered attention for its potential as a longevity enhancer and a combatant against age-related diseases. The ...
- The role of TOR signaling in enhancing graft success and crop vigoron April 16, 2024 at 11:24 am
A research team has delved into the Target of Rapamycin (TOR) signaling pathway in plant grafting, emphasizing its role in regulating seedling vigor, graft junction healing, and shoot-to-root ...
- Social Media Claims This FDA-Approved Pill Can Slow Down Aging. Can It?on April 16, 2024 at 4:01 am
Age discrimination is rampant, and beauty standards favor youth. So it’s no wonder that people do anything they can to push back on aging, whether that’s using Botox for fewer wrinkles, hair dye to ...
The Latest Google Headlines on:
Rapamycin
[google_news title=”” keyword=”rapamycin ” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]